The plasma levels of these redox biomarkers in total patient testicular GCT sample, and in particular among seminoma patients, analyzed with respect to individual NRF2, GSTM3, SOD2 and GPX3 genotypes are provided in Supplementary Tables (Tables S1 and S2). This evidence concerns the gene GPX3 and seminoma.